TITLE

Substantiation, According to FTC

AUTHOR(S)
Kalman, Douglas
PUB. DATE
June 2010
SOURCE
Nutraceuticals World;Jun2010, Vol. 13 Issue 5, p34
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the rules of the U.S. Federal Trade Commission (FTC) when calling a product substantiated. Factors used by the agency in review and consideration of substantiation include the type of product, type of claim, and the benefits of a truthful claim. The FTC says that these factors translate to reliable scientific evidence. For calling a product substantiated, it requires human clinical studies that conducted by different experts and conform to acceptable designs and protocols.
ACCESSION #
51086822

 

Related Articles

  • Trust but verify.  // Broadcasting & Cable;9/30/2002, Vol. 132 Issue 40, p50 

    Editorial. Focuses on the role of the Federal Trade Commission (FTC) in implementing commercial-speech regulation in the U.S. Overturn of the Federal Food Administration's ban on advertisements of compounded drugs; Details on First Amendment protection for commercial speech; Emphasis on FTC on...

  • A Busy Year for the FTC. Goldstein, Linda A.; Roth, Marc S.; King, Kawana T. // Response;Dec2011, Vol. 20 Issue 3, p47 

    The article focuses on the activities and efforts of the U.S. Federal Trade Commission (FTC) in 2011. The authors mention that the FTC has signaled its expectations to companies and marketers to conduct and rely on clinical studies to void weight-loss and other health claims. They add that the...

  • II. REGULATION OF PRODUCT CHARACTERISTICS. Werner, Ray O. // Journal of Marketing;Jan1964, Vol. 28 Issue 1, p77 

    The article presents information on legal developments in marketing relative to the regulation of product characteristics. The article presents the United States Federal Trade Commission's interpretation of the Flammable Fabrics Act. According to the Federal Trade Commission, handkerchiefs are...

  • THE FEDERAL TRADE COMMISSION AND UNFAIR METHODS OF COMPETITION IN FOREIGN COMMERCE. Ward, Alan S. // Antitrust Law Journal;1971, Vol. 40 Issue 4, p806 

    Examines the practices of competition in foreign commerce directed by the United States Federal Trade Commission. Assessment on the enforcement of the Federal Trade Commission Act on commercial operations; Scheme on the implementation of its provisions; Impact of the directives on the rates of...

  • Preserving Consumers' Claims and Defenses. Smith, Margery Waxman // American Bar Association Journal;Oct77, Vol. 63 Issue 10, p1400 

    Discusses the purpose and effect of the United States Federal Trade Commission's (FTC) promulgated trade regulation rule that provides that third-party holders of credit contracts are subject to claims and defenses the debtor could assert against the seller of goods or services obtained with...

  • Employees post online reviews? They must disclose relationship.  // HR Specialist: New Jersey Employment Law;Oct2010, Vol. 5 Issue 10, p1 

    The article offers information on the posting of employees' comments about the products of their companies through social networking sites in which the U.S. Federal Trade Commission (FTC) issued an Enforcement Guidelines requiring employees to disclose their relationships with their employer...

  • Definition of Made in America.  // Furniture/Today;8/13/2012, Vol. 36 Issue 47, p36 

    The article provides information on the definition of Made in America by the Federal Trade Commission (FTC), entailing that all or virtually all the product are made in the U.S.

  • FTC Extends Deadline for Comments on Textile Act.  // Home Textiles Today;1/9/2012, Vol. 33 Issue 2, p6 

    The article reports that the U.S. Federal Trade Commission has extended the deadline for comments on the Textile Fiber Products Identification Act.

  • FTC Eyes Anticompetitive Product Redesigns.  // Chain Drug Review;12/17/2012, Vol. 34 Issue 21, p93 

    The article reports on the amicus brief filed by the U.S. Federal Trade Commission before a federal court that asserts that minor and non-therapeutic changes to branded pharmaceutical product that impacts generic competition has the potential to violate antitrust laws.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics